Overall, we utilized multi-omics datasets from the GEO, TCGA, HCCDB, TISCH, and HPA databases to comprehensively explore the impact of G6PC1 on HCC prognosis, metabolic reprogramming, tumor immune microenvironment, drug sensitivity, and immunotherapy potential. Here, G6PC1 is linked to hepatocellular carcinoma.